Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123043242 | 12304324 | 2 | F | 20160321 | 20160629 | 20160426 | 20160706 | EXP | JP-ROCHE-1747203 | ROCHE | 74.06 | YR | M | Y | 63.00000 | KG | 20160706 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123043242 | 12304324 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Other | 125156 | .05 | ML | SOLUTION FOR INJECTION | QD | |||||||
| 123043242 | 12304324 | 2 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | 125156 | .05 | ML | SOLUTION FOR INJECTION | QD | |||||||
| 123043242 | 12304324 | 3 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | 125156 | .05 | ML | SOLUTION FOR INJECTION | QD | |||||||
| 123043242 | 12304324 | 4 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | 125156 | .05 | ML | SOLUTION FOR INJECTION | QD | |||||||
| 123043242 | 12304324 | 5 | C | DILTIAZEM. | DILTIAZEM | 1 | Oral | 0 | CAPSULE | ||||||||||
| 123043242 | 12304324 | 6 | C | EYLEA | AFLIBERCEPT | 1 | Unknown | 0 | |||||||||||
| 123043242 | 12304324 | 7 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | TABLET | ||||||||||
| 123043242 | 12304324 | 8 | C | LYRICA | PREGABALIN | 1 | Oral | 0 | CAPSULE | ||||||||||
| 123043242 | 12304324 | 9 | C | LOXONIN | LOXOPROFEN SODIUM | 1 | Oral | 0 | TABLET | ||||||||||
| 123043242 | 12304324 | 10 | C | LIMAPROST ALFADEX | LIMAPROST | 1 | Oral | 0 | TABLET | ||||||||||
| 123043242 | 12304324 | 11 | C | SELBEX | TEPRENONE | 1 | Oral | 0 | CAPSULE | ||||||||||
| 123043242 | 12304324 | 12 | C | MUCOSTA | REBAMIPIDE | 1 | Oral | 0 | TABLET | ||||||||||
| 123043242 | 12304324 | 13 | C | MECOBALAMIN | METHYLCOBALAMIN | 1 | Oral | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123043242 | 12304324 | 1 | Retinal vein occlusion |
| 123043242 | 12304324 | 2 | Macular oedema |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123043242 | 12304324 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123043242 | 12304324 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123043242 | 12304324 | 1 | 20150625 | 0 | ||
| 123043242 | 12304324 | 2 | 20150730 | 0 | ||
| 123043242 | 12304324 | 3 | 20151222 | 0 | ||
| 123043242 | 12304324 | 4 | 20160204 | 20160204 | 0 | |
| 123043242 | 12304324 | 6 | 20150903 | 0 |